U.S. Markets closed

Court affirms Edwards patents infringed, says injunction should be reconsidered

Edwards Lifesciences (EW) sued defendants CoreValve, a unit of Medtronic (MDT), over patent infringement related to a prosthetic device called a “transcatheter heart valve.” A district court jury ruled Edwards' patent to be valid and infringed by CoreValve and awarded damages of $72.65M in lost profits and $1.28M as a reasonable royalty. The district court entered judgment on the verdict, but declined to enhance damages for the willful infringement. The lower court also declined to issue an injunction against future infringement. The United States Court of Appeals for the Federal Circuit affirmed the district court’s rulings, except the appeals court remanded for reconsideration the lower court’s denial of an injunction.